167 related articles for article (PubMed ID: 27013005)
1. Step-by-Step Technique for Irreversible Electroporation of Focal Prostate Cancer: An Instructional Video Guide.
Ting F; Van Leeuwen PJ; Stricker PD
J Vasc Interv Radiol; 2016 Apr; 27(4):568. PubMed ID: 27013005
[TBL] [Abstract][Full Text] [Related]
2. Focal vs extended ablation in localized prostate cancer with irreversible electroporation; a multi-center randomized controlled trial.
Scheltema MJ; van den Bos W; de Bruin DM; Wijkstra H; Laguna MP; de Reijke TM; de la Rosette JJ
BMC Cancer; 2016 May; 16():299. PubMed ID: 27150293
[TBL] [Abstract][Full Text] [Related]
3. Focal Therapy of Prostate Cancer Using Irreversible Electroporation.
Valerio M; Ahmed HU; Emberton M
Tech Vasc Interv Radiol; 2015 Sep; 18(3):147-52. PubMed ID: 26365544
[TBL] [Abstract][Full Text] [Related]
4. Histopathological Outcomes after Irreversible Electroporation for Prostate Cancer: Results of an Ablate and Resect Study.
van den Bos W; Jurhill RR; de Bruin DM; Savci-Heijink CD; Postema AW; Wagstaff PG; Muller BG; Varkarakis IM; Skolarikos A; Zondervan PJ; Laguna Pes MP; de Reijke TM; de la Rosette JJ
J Urol; 2016 Aug; 196(2):552-9. PubMed ID: 27004693
[TBL] [Abstract][Full Text] [Related]
5. Why we should not routinely apply irreversible electroporation as an alternative curative treatment modality for localized prostate cancer at this stage.
Wendler JJ; Ganzer R; Hadaschik B; Blana A; Henkel T; Köhrmann KU; Machtens S; Roosen A; Salomon G; Sentker L; Witzsch U; Schlemmer HP; Baumunk D; Köllermann J; Schostak M; Liehr UB
World J Urol; 2017 Jan; 35(1):11-20. PubMed ID: 27147512
[TBL] [Abstract][Full Text] [Related]
6. Irreversible electroporation: ready for prime time?
Lu DS; Kee ST; Lee EW
Tech Vasc Interv Radiol; 2013 Dec; 16(4):277-86. PubMed ID: 24238383
[TBL] [Abstract][Full Text] [Related]
7. Effect of Focal vs Extended Irreversible Electroporation for the Ablation of Localized Low- or Intermediate-Risk Prostate Cancer on Early Oncological Control: A Randomized Clinical Trial.
Zhang K; Teoh J; Laguna P; Dominguez-Escrig J; Barret E; Ramon-Borja JC; Muir G; Bohr J; de Reijke TM; Pelechano Gómez P; Ng CF; Sanchez-Salas R; de la Rosette J
JAMA Surg; 2023 Apr; 158(4):343-349. PubMed ID: 36723911
[TBL] [Abstract][Full Text] [Related]
8. A randomized controlled trial on focal therapy for localized prostate carcinoma: hemiablation versus complete ablation with irreversible electroporation.
van den Bos W; Muller BG; de la Rosette JJ
J Endourol; 2013 Mar; 27(3):262-4. PubMed ID: 23469828
[No Abstract] [Full Text] [Related]
9. The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol.
van den Bos W; de Bruin DM; Muller BG; Varkarakis IM; Karagiannis AA; Zondervan PJ; Laguna Pes MP; Veelo DP; Savci Heijink CD; Engelbrecht MRW; Wijkstra H; de Reijke TM; de la Rosette JJMCH
BMJ Open; 2014 Oct; 4(10):e006382. PubMed ID: 25354827
[TBL] [Abstract][Full Text] [Related]
10. Irreversible electroporation for the treatment of localized prostate cancer: a summary of imaging findings and treatment feedback.
Scheltema MJ; Postema AW; de Bruin DM; Buijs M; Engelbrecht MR; Laguna MP; Wijkstra H; de Reijke TM; de la Rosette JJMCH
Diagn Interv Radiol; 2017; 23(5):365-370. PubMed ID: 28830850
[TBL] [Abstract][Full Text] [Related]
11. Irreversible electroporation (IRE): a narrative review of the development of IRE from the laboratory to a prostate cancer treatment.
Blazevski A; Scheltema MJ; Amin A; Thompson JE; Lawrentschuk N; Stricker PD
BJU Int; 2020 Mar; 125(3):369-378. PubMed ID: 31725935
[TBL] [Abstract][Full Text] [Related]
12. A Multicenter, Randomized, Single-blind, 2-Arm Intervention Study Evaluating the Adverse Events and Quality of Life After Irreversible Electroporation for the Ablation of Localized Low-intermediate Risk Prostate Cancer.
de la Rosette J; Dominguez-Escrig J; Zhang K; Teoh J; Barret E; Ramon-Borja JC; Muir G; Bohr J; de Reijke T; Ng CF; Leung CH; Sanchez-Salas R; Laguna P
J Urol; 2023 Feb; 209(2):347-353. PubMed ID: 36441776
[TBL] [Abstract][Full Text] [Related]
13. Irreversible Electroporation for the Ablation of Prostate Cancer.
Karagiannis A; Varkarakis J
Curr Urol Rep; 2019 Sep; 20(10):63. PubMed ID: 31478109
[TBL] [Abstract][Full Text] [Related]
14. Pilot Study to Assess Safety and Clinical Outcomes of Irreversible Electroporation for Partial Gland Ablation in Men with Prostate Cancer.
Murray KS; Ehdaie B; Musser J; Mashni J; Srimathveeravalli G; Durack JC; Solomon SB; Coleman JA
J Urol; 2016 Sep; 196(3):883-90. PubMed ID: 27113966
[TBL] [Abstract][Full Text] [Related]
15. Novel focal therapy treatment options for prostate cancer.
Werntz RP; Eggener SE
Curr Opin Urol; 2018 Mar; 28(2):178-183. PubMed ID: 29232270
[TBL] [Abstract][Full Text] [Related]
16. Irreversible electroporation, a new modality in Focal Therapy for prostate cancer.
Scheltema MJ; van den Bos W; Wagstaff PG; Postema AW; de Bruin DM; Laguna Pes MP; de la Rosette JJ
Arch Esp Urol; 2016 Jul; 69(6):337-44. PubMed ID: 27416637
[TBL] [Abstract][Full Text] [Related]
17. Will focal therapy remain only an attractive illusion for the primary treatment of prostate cancer?
Giannarini G; Gandaglia G; Montorsi F; Briganti A
J Clin Oncol; 2014 May; 32(13):1299-301. PubMed ID: 24687824
[No Abstract] [Full Text] [Related]
18. A systematic review of irreversible electroporation in localised prostate cancer treatment.
Morozov A; Taratkin M; Barret E; Singla N; Bezrukov E; Chinenov D; Enikeev M; Gomez Rivas J; Shpikina A; Enikeev D
Andrologia; 2020 Nov; 52(10):e13789. PubMed ID: 32786087
[TBL] [Abstract][Full Text] [Related]
19. MRI-guided focal therapy of prostate cancer.
Mathew MS; Oto A
Future Oncol; 2017 Mar; 13(6):537-549. PubMed ID: 27776423
[TBL] [Abstract][Full Text] [Related]
20. Electrical breakdown in tissue electroporation.
Guenther E; Klein N; Mikus P; Stehling MK; Rubinsky B
Biochem Biophys Res Commun; 2015 Nov; 467(4):736-41. PubMed ID: 26482855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
